UNSPSC 85672508: Supplement left thorax bursa and ligament with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left thorax bursa and ligament with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0MUG07Z

UNSPSC 85672508 Supplement left thorax bursa and ligament with autologous tissue substitute, open approach is a Commodity code that nominally describes a specific surgical procedure, but recent state and local procurement activity shows no solicitations actually seeking this service. The code's narrow technical scope—orthopedic surgical repair using autologous tissue—does not align with the health and human services contracts now being posted under this designation.

State and local governments are currently using this code to solicit unrelated services: independent medical evaluation and disability determination support (City of Phoenix Retirement Office), surgical benefit carve-out programs for employee health plans (City of Long Beach), occupational medical surveillance (Washington State Department of Transportation), specialty and emergency medical services for youth in detention (Harris County Juvenile Probation Department), pharmacy benefit management (Collier County), and temporary ancillary health professional staffing (County of Santa Clara Health System). The issuing bodies span municipal retirement systems, county human resources departments, state transportation agencies, detention authorities, and county health systems across Arizona, California, Florida, and Washington. No opportunity in the recent-opportunity block solicits thoracic or ligament surgical procedures or implant services. The code shows substantial recent activity, but virtually none of it is decision-relevant to firms pursuing orthopedic surgery or tissue-substitute supply contracts—the activity reflects a taxonomy mismatch rather than a market signal for the commodity the code nominally names.